Position in ATYR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$743,352
-$149,408 QoQ
Shares Held
1,245,147
+8.8% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 90 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. ATYR ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ATYR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $743,352 | 1,245,147 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $892,760 | 1,144,565 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $355,828 | 454,443 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $152,131 | 211,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $158,832 | 31,328 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,161 | 22,239 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $78,293 | 21,628 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $19,671 | 10,088 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $37,418 | 26,538 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $145,884 | 92,332 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $908,474 | 420,590 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $263,793 | 125,616 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $355,958 | 162,538 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $540,042 | 180,014 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $505,316 | 178,557 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,258,517 | 235,237 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,637,837 | 486,993 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,918,826 | 541,721 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $70,496 | 14,446 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $181,684 | 46,826 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $492,491 | 152,474 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $586,626 | 132,123 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $179,953 | 64,269 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||